Physician

Shani Kotadia, MD

According to 2025 Medicare claims, Shani Kotadia, MD (NPI: 1619256807) practices nephrology in the Sierra Vista-Douglas, AZ market, with the plurality of this provider's patient population coming from Cochise, AZ. This provider's primary affiliated billing organization is SOUTHWEST KIDNEY INSTITUTE, PLC (NPI: 1659316008; TIN: 860846208) and primary practice location at 85712-1591. Kotadia is affiliated with the Innovation Care Partners MSSP (ACO ID: A2029), ABC Network (ACO ID: A5554), and Accountable Care Coalition of Direct Contracting, LLC (ACO ID: D0115), participating under both the MSSP and REACH models.

Kotadia's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 711 traditional Medicare patients, billed 5,520 HCPCS/CPT codes, and received $208,027 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 3,538 prescription claims across 616 beneficiaries totaling $328,485 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 24 claims. Open Payments data shows 18 records totaling $303. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $1,215 to $328,485. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$151K$301K2016 Medicare payment: $22,100 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $203,297 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $301,353 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $256,200 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $214,445 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $190,432 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $171,964 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $179,996 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $208,027 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
201672223$22,100
20175722,368$203,297
20188693,350$301,353
20198423,066$256,200
20207622,818$214,445
20217602,557$190,432
20227162,763$171,964
20237083,154$179,996
20247115,520$208,027

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$256K$513K2015 Drug cost: $1,215 (USD; Tot_Drug_Cst)2016 Drug cost: $6,555 (USD; Tot_Drug_Cst)2017 Drug cost: $87,412 (USD; Tot_Drug_Cst)2018 Drug cost: $219,063 (USD; Tot_Drug_Cst)2019 Drug cost: $171,097 (USD; Tot_Drug_Cst)2020 Drug cost: $228,143 (USD; Tot_Drug_Cst)2021 Drug cost: $253,717 (USD; Tot_Drug_Cst)2022 Drug cost: $395,534 (USD; Tot_Drug_Cst)2023 Drug cost: $512,756 (USD; Tot_Drug_Cst)2024 Drug cost: $328,485 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152290$1,215
201646141$6,555
20171841,272$87,412
20183743,150$219,063
20194763,502$171,097
20205123,849$228,143
20215633,925$253,717
20226103,927$395,534
20235673,291$512,756
20246163,538$328,485

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$5.0K$10K2017 Medicare payment: $3,951 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $9,563 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $5,294 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $4,647 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $10,015 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $3,309 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $531 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R92$3,951
2018N/R156$9,563
2019N/R166$5,294
2020N/R173$4,647
2021N/R281$10,015
2022N/R124$3,309
2023N/RN/RN/R
2024N/R24$531

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes116308$89
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more391719$87
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes114285$58
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's457847$12
80069Kidney function blood test panel101175$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FarxigaDapagliflozin Propanediol312,640$48,691
JardianceEmpagliflozin211,440$28,472
KerendiaFinerenone191,290$26,763
LokelmaSodium Zirconium Cyclosilicate321,096$16,885
ProsolParenteral Amino Acid 20% No.167469$13,237

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J7517Mycophenolate mofetil, oral, 250 mgNN/R12$305
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R12$226

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.18$303Boehringer Ingelheim Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Shani Kotadia, MD?

Tedicare shows public-source Medicare data for Shani Kotadia, MD (NPI 1619256807), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shani Kotadia, MD have ACO affiliation data?

Shani Kotadia, MD is shown with ACO affiliation data for Innovation Care Partners MSSP (MSSP, ACO ID A2029), ABC Network (MSSP, ACO ID A5554), and Accountable Care Coalition of Direct Contracting, LLC (REACH, ACO ID D0115).

What billing organization is linked to Shani Kotadia, MD?

Shani Kotadia, MD is linked to SOUTHWEST KIDNEY INSTITUTE, PLC (billing NPI 1659316008) in the available physician profile data.

Does Shani Kotadia, MD have Open Payments data?

Shani Kotadia, MD has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.